Could increasing levels of IL-7 in patients help combat sepsis?

In a recently published study, researchers from Washington University School of Medicine (WUSM; MO, USA) reveal that an IL-7 drug could be used in sepsis patients to boost their adaptive immunity, potentially offering a new strategy to improve survival rates in future.

Sepsis develops when an infection triggers an overwhelming immune response and is said to cause around 250,000 deaths annually in the USA. Standard treatment of the condition currently involves high doses of antibiotics to fight the infection; however, this often fails to boost the body’s immune defenses.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment